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Background: Prior studies indicated improved early mortality and paraplegia rates in a small cohort of patients with type
I-III thoracoabdominal aortic aneurysms (TAAs) treated with atriofemoral bypass (AFB) and motor-evoked potentials
(MEVPs) when compared with a propensity-matched cohort of patients treated with the clamp and sew (CS) method,
wherein epidural cooling was the principal spinal cord protective adjunct. The use of AFB/MEVP increases the
complexity of TAA repair and in this study, we address whether the early beneﬁts will be sustained when this is applied to
a general population with type I-III TAAs.
Methods: Consecutive patients undergoing repair of nonruptured Crawford extent I-III TAAs from 1/1987 to 12/2011
were identiﬁed. Patients were stratiﬁed according to operative approach (AFB/MEVP vs CS). Endpoints included long-
term survival, and the composite outcome of perioperative death and paraplegia. A multivariate, risk-adjusted model was
then created to determine if operative approach independently inﬂuenced outcome.
Results: There were 485 patients (CS [ 385 [79%]; AFB/MEVP [ 100 [21%]). The cohorts differed in that the
AFB/MEVP group was younger (65.86 12.5 years vs 70.96 9.7 years; P < .001), had more extent I/II aneurysms (66%
vs 50.1%; P[ .005), and had more chronic dissections (30.3% vs 18.9%; P[ .018). Operative variables differed in that
the AFB/MEVP cohort had longer operative times (4346 112 minutes vs 3246 98 minutes; P < .001) and higher blood
turnover (6028 6 3473 mL vs 3581 6 3111 mL; P < .0001). There was no difference in the rate of intraoperative
death (AFB/MEVP [ 1.0% vs CS [ 0.5%; P [ .50), length of intensive care unit stay (AFB/MEVP [ 9.6 6 8.6
days vs CS [ 9.5 6 12.3 days; P [ .95) or hospital length of stay (AFB/MEVP [ 19.9 6 12.6 days vs CS [ 21.6 6
23.5 days; P[ .49). The composite perioperative death and paraplegia rate was lower in the AFB/MEVP cohort (7% vs
19%; P [ .004). The multivariate model for predictors of the composite outcome showed that AFB/MEVP was
protective (odds ratio, 0.39; 95% conﬁdence interval, 0.17-0.9; P[ .028). Long-term (4-year) survival was improved in
the AFB/MEVP group as well (73 6 6% vs 60 6 3%; P [ .004).
Conclusions: AFB/MEVP is an independent predictor of improved perioperative death and paraplegia rates as well as
long-term survival in patients undergoing repair of type I-III TAAs and is the preferred operative strategy. (J Vasc Surg
2013;58:283-90.)The operative techniques used to repair extensive aneu-
rysmal disease of the thoracoabdominal aorta (extent I-III)
have evolved signiﬁcantly over the last quarter-century.the Division of Vascular and Endovascular Surgery, Massachusetts
eneral Hospital, Harvard Medical School.
or conﬂict of interest: none.
ented at the Thirty-ninth Annual Meeting of the New England Society
r Vascular Surgery, Boston, Mass, September 22, 2012.
rint requests: Richard P. Cambria, MD, Massachusetts General
ospital, 15 Parkman St e Wang ACC 440, Boston, MA 02114
-mail: rcambria@partners.org).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2013 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2013.01.042E. Stanley Crawford, MD, established the modern era of
open surgical treatment, championing a simpliﬁed surgical
approach, and his summary results remain in a real sense
the surgical standard.1 Progressive addition of a number
of surgical adjuncts has improved surgical outcomes, in
particular with respect to perioperative spinal cord ischemic
complications.2 As more sophisticated surgical adjuncts
have arisen, it is worthy of emphasis that only cerebrospinal
ﬂuid (CSF) drainage is supported by what could be consid-
ered an adequate evidence base,3,4 and there remains no
consensus on the use of technical strategies such as inter-
costal reimplantation and/or evoked potential monitoring.
Routine intercostal artery reimplantation is often
employed, but prior reports have shown that this leads
to prolonged operative times and increased blood loss.4-7
In addition, the experience with both selected open283
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(TEVAR) literature indicate that intercostal reconstruc-
tion is seldom necessary.8-10 Furthermore, delineation of
the spinal cord collateral network concept, as described
by Griepp et al, and its apparent validation with both clin-
ical observations11 and pre- and postoperative magnetic
resonance angiography studies12 have largely supplanted
theories of critically important intercostal vessels. Finally,
studies employing the use of motor-evoked potentials
(MEVPs) have shown that intercostal reimplantation can
be selectively applied, as guided by such intraoperative
monitoring.13,14
In an effort to further reduce spinal cord ischemic
complications, our operative strategies have evolved from
the traditional clamp and sew (CS) technique with epidural
cooling for cord protection, to one applying distal aortic
perfusion with MEVP monitoring.7,14 The concept, of
course, is to support the spinal cord’s collateral network
throughout the conduct of the operation and to have real
time data on the status of spinal cord circulation.
Preliminary results with this strategy were previously
published and showed improved early mortality and para-
plegia rates, as compared with a CS technique, using
a matching protocol based on propensity scores. In that
series, small cohorts of patients from the atriofemoral
bypass (AFB) and CS groups were matched for expected
preoperative risk for spinal cord ischemia, and compared.14
Now that this series has matured, we report the results
of a larger cohort of patients undergoing repair of extent
I-III thoracoabdominal aortic aneurysms (TAAs), with an
aim to further characterize the effect of AFB with MEVP
monitoring on overall outcomes, including long-term
survival.
METHODS
Data source. Under approval of the Institutional
Review Board, prospective data collection of demographic,
preoperative, intraoperative, and 30-day postoperative
variables was completed for all patients undergoing repair of
thoracic or thoracoabdominal aneurysms between January
1987 and December 2011 at a single tertiary medical
center.
Standardized deﬁnitions were applied for clinical
comorbidities. Each patient’s self-reported medical history,
in addition to medical comorbidities reported in the
medical record, was recorded. Chronic renal failure was
deﬁned as preoperative creatinine >1.8 mg/dL or the
need for preoperative hemodialysis. Aneurysm extent was
deﬁned according to the original Crawford classiﬁcation
(classiﬁcation as extent I/II requires resection of the entire
descending thoracic aorta),15 and was determined from
operative records based on clamp locations and required
visceral reconstructions.
Operative time was recorded from the operating
room nursing record. Estimated blood loss, volume of
blood products returned to the patient, volume of crystal-
loids/colloids given, and urine output were determined
from the anesthesia records. Clamping times are recordedin both the operative record and the anesthesia record, and
both were used to determine times recorded for data anal-
ysis. In instances where these two numbers did not corre-
late, the anesthesia documents were considered correct.
Reimplantation of intercostals (both number and level of
vessels reconstructed), along with the use of in-line mesen-
teric shunting and renal stent use was recorded from the
operative note.
Postoperative data was prospectively recorded by in
independent nurse reviewer. The incidence of early postop-
erative death (within 30 days), as well as hospital and inten-
sive care unit length of stay, were gathered from the
inpatient hospital record and from hospital administrative
data. The incidence of neurologic events was determined
from the medical record, as well as from records from post-
operative visits. Speciﬁcally, any neurologic deﬁcit which
was not true paraplegia was categorized as paraparesis.
Cardiac, pulmonary, renal, and infectious complications
were determined from review of the patient’s in-hospital
medical record.
This database was queried for all patients with non-
ruptured extent I, II, or III TAAs for inclusion in the study
cohort. All ruptured aneurysms, isolated descending thoracic
aneurysms, and extent IV aneurysms were excluded.
Statistical analysis. All statistical analyses were per-
formed using SAS software (version 9.2; SAS Institute,
Cary, NC).
Univariate comparisons. The cohort of patients was
divided into those who underwent repair of TAAs with
a CS technique, vs those who underwent repair with AFB
and MEVP monitoring. Preoperative, operative, and post-
operative variables were evaluated for these two groups.
For each comparison, the Fisher exact test was used for
discrete variables, the t-test with equal variances was used
for normally distributed continuous variables, and the Wil-
coxon rank-sum test was used for non-normally distributed
continuous and ordinal variables.
Actuarial survival analysis was performed using Kaplan-
Meier methods. A value of P # .05 was used to delineate
signiﬁcance.
Multivariate modeling. Due to the low number of
perioperative deaths and permanent paraplegia, a composite
of these two occurrences was modeled using stepwise
logistic regression. The number of candidate predictors
was determined by the frequency of the composite occur-
rence within the cohort. In addition to those variables
that were deemed clinically relevant, all preoperative and
demographic variables that were missing in less than 10%
of the patients AND which correlated with the composite
outcome (P < .15) were considered for inclusion in the
ﬁnal risk-adjustment model. Of note, variables felt to be
clinically relevant (ie, Crawford extent, nonelective status,
age, and the presence of dissection) were forced into the
multivariate model. A signiﬁcance level of 0.05 was the
threshold chosen for the stepwise procedure, and thus was
the threshold for a variable to enter the model.
A Cox model of proportional hazard for death was
constructed using a backward selection procedure.
Table I. Preoperative and demographic data
Without bypass and
MEVP, % (n ¼ 385)
With bypass and
MEVP, % (n ¼ 100) P value
Male 43.9 50.0 .310
Age, years 70.9 6 9.7 65.8 6 12.5 <.001
Diameter, cm 6.9 6 1.5 6.5 6 1.1 .041
Crawford
I 32.0 44.0 .015
II 18.2 22.0
III 49.9 34.0
Dissection 19.0 30.3 .018
Diabetes 7.0 14.0 .041
History of cerebrovascular accident 7.8 6.0 .668
Hypertension 88.8 90.0 .858
Coronary artery disease 46.8 23.0 <.001
History of myocardial infarction 15.6 10.0 .197
History of atrial ﬁbrillation 10.3 12.0 .588
History of congestive heart failaure 5.3 7.0 .472
History of smoking 82.9 76.0 .148
Chronic obstructive pulmonary disease 20.8 22.0 .784
History of chronic renal insufﬁciency 10.0 10.0 1.0
Preoperative Cr 1.30 6 0.7 1.18 6 0.5 .125
History of peripheral vascular disease 16.0 15.0 .878
Family history of aneurysm 8.4 17.0 .015
Abdominal aortic aneurysm 20.5 25.0 .340
Marfan syndrome 2.8 7.0 .066
Turner’s 0 3.0 .010
Cr, Creatinine; MEVP, motor-evoked potential.
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chosen for a variable to remain in the model.
Surgical technique. Prior to July 2006, we generally
applied epidural cooling and an aggressive posture towards
intercostal reconstruction in the T9-L1 regions when
technically feasible.7,16-18 During this period, the use of
distal aortic perfusion was reserved for patients with
complex anatomy in the region of the proximal anasto-
mosis or severe renal dysfunction.19 In 2006, however, the
surgical practice was uniformly modiﬁed to include the use
of distal aortic perfusion via AFB for all patients with extent
I-III disease. The adjunct of MEVP neuromonitoring was
also uniformly applied to all patients as a means to direct
selective intercostal reimplantation, as driven by changes in
MEVPs.14
CS with adjuncts. Details of the CS technique and
the epidural infusion system have been previously re-
ported.16,18,19 The CS technique is predicated upon the
principles of simplicity and expediency.
Patent intercostal vessels in the T9-L1 region were
reconstructed by means of either a separate inclusion
button or these vessels were preserved with a beveled anas-
tomosis when technically feasible. Renal protection was
initiated with a 250 mL bolus of renal preservation ﬂuid
(4C lactated Ringer’s with 25g of mannitol/liter and 1g
methyl prednisolone/liter) followed by a continuous infu-
sion that maintained the renal core temperature at 25C;
the left renal artery is routinely reconstructed with a
sidearm graft, and stenotic lesions of the right renal artery
are frequently managed with direct placement of a balloon
expandable stent.20In order to blunt the profound metabolic and hemody-
namic disturbances that occur after restoration of blood
ﬂow to the mesenteric circulation,17 in-line mesenteric
shunting was accomplished through a temporary sidearm
graft. A 20F to 24F arterial perfusion catheter was attached
to the sidearm graft; and, immediately after completion
of the proximal anastomosis, antegrade pulsatile perfusion
was established into either the celiac axis or superior
mesenteric artery in order to minimize visceral ischemic
time and its potential contribution to coagulopathic
bleeding.17 Following reperfusion of the lower extremities,
epidural cooling was discontinued and continuous passive
CSF drainage was continued for 48 hours.14
AFB with MEVP. AFB is initiated by cannulation of
the left atrium through the left inferior pulmonary vein
and the arterial return is usually via the left common
femoral artery. Flows are initially adjusted to maintain distal
mean perfusion pressures of at least 60 to 70 mm Hg. A
single dose (usually an empiric dose of 5000u) of heparin
is administered upon insertion of the left atrial cannula.
Since the circuit utilizes heparin-impregnated tubing, line
thrombosis (which has not been observed) is a risk only if
ﬂow needs to be interrupted. MEVPs are monitored by
a dedicated neurologist who is able to address technical
issues such as patient response to anesthetic agents and
electrode failure. Any true deterioration in MEVP prompts
either an increase in the stimulus intensity or an increase in
distal perfusion pressures. A sudden drop in MEVP
amplitude (occurring within 2-10 minutes) or a sustained
progressive drop (within 10-40 minutes) of >75% from
baseline is considered signiﬁcant.21 If MEVPs do not
Table II. Intraoperative data
Without bypass and
MEVP (n ¼ 385)
With bypass and
MEVP (n ¼ 100) P value
Operative time, minutes 324.1 6 98.2 434.3 6 111.9 <.001
Nonelective, % 24.3 11.0 .004
Estimated blood loss, mL 3581 6 3111 6028 6 3473 <.001
Cell saver, mL 1598 6 1453 2794 6 1599 <.001
Fresh frozen plasma given, units 5.6 6 3.5 9.7 6 6.3 <.001
Platelets given, units 10.0 6 5.2 8.8 6 6.5 .090
Albumin, mL 882 6 565 1687 6 988 <.001
Crystalloid, mL 2173 6 1332 3088 6 1568 <.001
Urine output, mL 725 6 528 1031 6 739 <.001
Epidural cooling, % 69.0 5.0 <.001
Aorto-femoral bypass, % 11.1 100 <.001
Mesenteric shunt, % 37.2 33.0 .540
Any intercostal reimplantation, % 65.5 7.0 <.001
MEVP, % 0.3 100 <.001
Splenectomy, % 18.4 33.7 .002
R renal stent, % 10.6 7.5 .485
Total XClamp, minutes 75.5 6 29.0 90.4 6 47.9 <.001
MEVP, Motor-evoked potential.
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reconstruction via an inclusion button is performed. If the
MEVPs were unchanged, any patent/backbleeding inter-
costal vessels were oversewn. In the instances where
intercostal arteries were reimplanted, these were always in
the T9-L1 segments. Sequential clamping, which varies
according to lesion anatomy, allows continuous renal and
visceral perfusion during the creation of the proximal
anastomosis, and in-line mesenteric shunting is used
selectively, as described above.14,17,18
RESULTS
Between January 1987 and December 2012, 485
patients underwent repair of extent I-III TAAs. Extent I
and II aneurysms were found in over half of the patients
(53.4%) while extent III aneurysms were found in only
46.6%. One hundred patients underwent repair of their
aneurysm with the use of distal aortic perfusion via AFB
with MEVP (20.6%), while the remaining 385 patients
(79.4%) underwent repair with a CS technique. The
routine use of AFB/MEVP was the only change over
the study period. The same surgeon, anesthesia team,
patient selection, and use of intensive care unit care were
in place for the 25-year period. Table I demonstrates the
comparison of preoperative and demographic characteris-
tics between the AFB and CS groups.
The mean aneurysm size was minimally smaller in the
AFB/MEVP group (6.5 cm vs 6.9 cm; P ¼ .04), but aneu-
rysm anatomy was more complex in this group. There were
more extent I and II aneurysms in the distal perfusion
group, as compared with the CS group (66% vs 50.2%;
P ¼ .005). Additionally, the incidence of dissection was
signiﬁcantly higher in the AFB/MEVP group (30.3% vs
19%; P ¼ .018). The preoperative incidence of coronary
disease was higher in the CS group (46.8% vs 23%; P <
.001), while the incidence of diabetes was higher in theAFB/MEVP group (14% vs 7%; P ¼ .041). The difference
in the incidence of coronary disease is likely related to the
differences in the population ages and incidence of dissec-
tion between the groups.
The operative time was longer (434.36 111.9 minutes
vs 324.1 6 98.2 minutes; P < .001) and the blood loss was
greater (6028 6 3473 mL vs 3581 6 3111 mL; P < .001)
in the AFB/MEVP group, as compared with the CS group
(Table II). Further, the use of neuromonitoring allowed
for reduced/selective reimplantation of intercostal arteries
in the distal perfusion group (7% vs 65.5%; P < .001).
AFB for distal aortic perfusion was employed in 11.1% of
cases in the CS group, generally reserved for patients
with very complex anatomy and/or poor renal function.
In these instances, MEVP was not employed.
There was no difference in intraoperative death (CS ¼
0.5% vs AFB¼ 1.0%; P¼ .501). The incidence of early post-
operative death was reduced by half in the AFB/MEVP
group, a difference that trended toward signiﬁcance (9.9%
vs 4.0%; P ¼ .072; Table III). There was also no difference
in the hospital length of stay, nor in the intensive care unit
length of stay. Importantly, the use of distal aortic perfusion
and neuromonitoring lead to a signiﬁcant reduction in the
incidence of permanent spinal cord injury (3.0% vs 11.9%;
P ¼ .008). The risk of stroke was reduced from 10.4% to
3.0% (P ¼ .018). Overall, however, the incidence of non-
neurologic complications was quite similar between the
groups. There was, however, a trend toward a lower inci-
dence of renal failure requiring hemodialysis in the AFB/
MEVP group (5.1% vs 11.4%; P ¼ .063). Long-term (4-
year) survival (Fig) was improved in the AFB/MEVP group,
as well (73 6 6% vs 60 6 3%; P ¼ .004). As shown in
Table IV, after risk adjustment for age, gender, and a variety
of preoperative risk factors, the use of AFB/MEVP was
shown to be an independent predictor of long-term survival
(proportional hazard ratio, 0.59; P ¼ .046).
Fig. Long-term survival stratiﬁed by operative strategy. The
4-year survival for the atriofemoral bypass/motor-evoked potential
(AFB/MEVP) group was 73% 6 6%, vs 60.0% 6 3% in the clamp
and sew (CS) cohort (P ¼ .004).
Table IV. Cox proportional hazard model for long-term
survival
Variable
Hazard
ratio
95% conﬁdence
interval P value
AFB/MEVP cohort 0.590 0.35-0.99 .046
Male (vs female) 0.674 0.53-0.85 .001
Hypertension 1.608 1.09-2.37 .016
Age, years 1.040 1.03-1.06 <.001
Preoperative renal failure 1.359 1.22-1.51 <.001
AFB/MEVP, Atriofemoral bypass/motor-evoked potential.
Table III. Postoperative data
Without bypass
and MEVPa
(n ¼ 385)
With bypass
and MEVPa
(n ¼ 100) P value
Intraoperative death 0.5 1.0 .501
Early postoperative death 9.9 4.0 .072
Intensive care unit
LOS, days
9.5 6 12.3 9.6 6 8.6 .947
Hospital LOS, days 21.6 6 23.5 19.9 6 12.6 .492
Permanent SCI 11.9 3.0 .008
Permanent SCI/death 14.1 7.0 .003
Immediate paraplegia 7.3 2.0 .058
Delayed paraplegia 1.7 1.0 .236
Immediate paraparesis 2.8 3.0 1.0
Delayed paraparesis 2.8 6.0 .130
Stroke 10.4 3.0 .018
Myocardial infarction 4.2 4.0 1.0
Pulmonary complication 54.3 41.7 .072
Tracheostomy 14.9 7.5 .064
Hemothorax 0.8 4.0 .043
Resperatory failure 15.7 9.1 .106
Pneumonia 16.8 34.3 <.001
Reintubation 15.1 16.2 .875
Pulmonary embolism 1.8 1.0 1.0
Gastrointestinal
complication
5.5 15.2 .002
Acute renal failure with
hemodialysis
11.4 5.1 .063
Highest Cr, mg/dL 2.1 6 1.7 1.6 6 1.0 .006
Wound infection 6.8 5.1 .650
Graft infection 0.3 0 1.0
Sepsis 8.1 5.0 .393
Multiorgan failure 6.5 3.1 .234
Cr, Creatinine; LOS, length of stay; MEVP, motor-evoked potential; SCI,
spinal cord injury.
a% unless otherwise indicated.
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rate was signiﬁcantly lower in the AFB/MEVP group
(7.0% vs 14.1%; P ¼ .003). For the subset of patients
in the CS group who underwent repair with the use of
AFB (without MEVP), the mortality/paraplegia rate was
25.6%, reﬂecting the application of this strategy in the
most complex cases. As seen in Table V, after applying
a step-wise selection procedure in order to risk-adjust for
preoperative and intraoperative differences between the
groups (including nonelective status), this improvement in
the composite outcome with AFB/MEVP persisted (odds
ratio, 0.39; 95% conﬁdence interval, 0.17-0.9; P ¼ .028).
DISCUSSION
Despite satisfactory results over a long interval with
TAA repair,19 our operative strategy evolved to the present
approach primarily related to the inability to further reduce
spinal cord ischemic complications with a clamp sew/
epidural cooling technique.14,19
Our current approach of AFB with neuromonitoring
was prompted by the collateral network concept of cord
circulation, rather than the theory of spinal cord circula-
tion being critically dependent on individual intercostal
vessels, as described by Griepp et al.11,22 Furthermore,magnetic resonance imaging studies, reported by Jacobs
et al,12,23 were both conﬁrmatory of this concept and
emphasized the importance of the pelvic (hypogastric)
collateral circulation. Accordingly, this pelvic network can
be continuously supported with a distal perfusion tech-
nique where distal perfusion pressures are monitored.24
The existence of such collateral vessels argues in favor of
assisted circulation techniques to support collateral perfu-
sion of the cord intraoperatively during cross-clamp appli-
cation. Jacobs et al clinically observed that, in patients
with complete occlusion of lower thoracic intercostal
vessels, MEVPs were highly dependent upon maintenance
of pelvic perfusion using AFB. Further, rapid deterioration
in MEVP amplitudes with temporary discontinuation of
the bypass circuit during distal clamp application was
noted.12 Clinical and physiological support for this has
been provided using intraoperative MEVP monitoring to
detect spinal cord ischemia, and this is the rationale for
selective intercostal reimplantation.12,13,23 This same
posture of support of the spinal cord collateral network is
not applied to the repair of extent IV TAA, as we and
others have reported that those with extent IV aneurysms
have a low risk of spinal cord injury, regardless of operative
technique or use of adjunct measures. For aneurysms of
Table V. Risk-adjustment model for composite outcome
of death/paraplegia
Variable Odds ratio
95% conﬁdence
interval P value
AFB/MEVP cohort 0.384 0.17-0.90 .025
Crawford III 0.72 0.42-1.24 NS
Age, years 1.03 0.99-1.06 NS
Nonelective 1.64 0.93-2.87 NS
Dissection 1.72 0.89-3.33 NS
Pre-op renal failure 2.25 1.18-4.51 .023
AFB/MEVP, Atriofemoral bypass/motor-evoked potential.
c-statistic ¼ 0.70.
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ciency is favored.25-27
The results described in the present series, especially
the results of those patients undergoing repair with
AFB/MEVP, compare favorably with those at other
centers of excellence. A recent series of 509 patients under-
going open repair of type I-IV TAAs was reported by
Wong et al.28 In that series, 384 of the patients underwent
repair of extent I-III TAAs. In that subset of patients,
operative mortality was 7.8%, and the rate of permanent
paraplegia was 7.6%. This is in comparison to 4.0% and
3.0%, respectively, in the current series. However, it is
noteworthy that the report of Wong et al does include
a small portion of patients who suffered aneurysm rupture
(4.7%), whereas the current series has excluded such
patients. The overall results, therefore, are quite similar.
Another large series, reported by Saﬁ et al, describes
the results of 1004 patients undergoing repair of TAAs
(extent I-V), in which the adjuncts of distal aortic per-
fusion and CSF drainage were used in 75% of patients.29
Neuromonitoring in the form of electroencephalography
and somatosensory-evoked potentials was also used in
that series. The results of the present study compare favor-
ably with those described there. In that series, approxi-
mately 15% of patients were treated for extent IV TAAs.
Nonetheless, the 30-day mortality was reported at 14%
for that cohort, and immediate neurologic deﬁcit was
found in 3.6% of the cohort. As was the case in our expe-
rience, the report by Saﬁ et al showed that the adjunctive
use of spinal cord protection strategies did, however,
reduce the incidence of neurologic deﬁcit.29,30
The results reported herein also compare favorably
with those of the composite review reported by Acher
and Wynn. In their review of 25 years of clinical experience
in more than 15,000 patients treated for TAAs, the mean
mortality rate in single-center series is 12.5%.2 Since
1997, this rate has declined to approximately 8.8%. They
report that, on multivariate analysis, age and paraplegia
are the most signiﬁcant predictors of perioperative death.
Thus, it follows that as the risk of paraplegia has declined
over the last 25 years e and in the present series e due
to various spinal cord protection strategies, that the risk
of operative mortality would also decline. As in previous
reports, we emphasize that the results reported here reﬂectoutcomes achieved in high-volume centers of excellence.
Cowan et al queried the National Inpatient Sample to
demonstrate that both hospital volume and surgeon
volume were independent predictors of overall mortality.31
Administrative database studies indicate that, in so-called
“real-world experience,” there is prohibitive risk associated
with open TAA repair, with 30-day mortality rates in excess
of 20%.31,32 Further, it has been shown by Rigberg et al
that, in a statewide experience, mortality at 1 year is signif-
icantly higher than that reported in the perioperative
period, which in turn emphasizes the importance of late
survival data.32
In the present series, long-term survival is shown to
be improved with the use of AFB/MEVP. The 4-year
survival of 73% in the AFB/MEVP cohort compares favor-
ably with the long-term survival reported by other centers
of excellence.29,30 Perhaps more importantly, however,
the long-term survival demonstrated with the use of
AFB/MEVP equates the long-term survival reported by
our group after open repair of standard infrarenal aortic
aneurysms.33 This indicates that the resource investment
in the care of patients with extent I-III TAAs appears
well justiﬁed.
Some centers favor the use of cardiopulmonary bypass
with intervals of hypothermic circulatory arrest (HCA) as
a technique to protect the spinal cord during repair of
TAAs, citing advantages of minimal aortic dissection, elim-
ination of the need for aortic clamping, a bloodless ﬁeld, and
reduced potential of atheromatous embolization.34 A report
of 218 patients by Kulik et al demonstrated a 30-day
mortality of 7.3% and immediate spinal cord ischemia rate
of 4.6% (3.7% paraplegia).35 Five-year survival was 55% in
the HCA group, as compared to a 4-year survival of 73%
in the present series. Largely due to the extensive surgical
ﬁeld required for extent I-III TAA repair, and major issues
with intraoperative bleeding, most surgeons use HCA
only when no other technical option exists to repair the
aneurysm,28,36 a position with which we concur.
Although the present study does not speciﬁcally
consider endovascular and hybrid alternatives to open
repair of TAAs, comparison of the present results to these
TEVAR-based alternatives is appropriate. Hybrid ap-
proaches with visceral or renal debranching have not
produced outcomes comparable to the present report,
either in our own experience or that reported from the
North American Complex Abdominal Aortic Debranching
Registry. In the latter report, operative mortality for a cohort
of 130 type I-III TAAs was 14% with a 10% paraplegia
rate.37 In our experience, hybrid procedures were applied
after commercial availability of TEVAR, for only those
patients who were otherwise deemed unﬁt for a standard
open repair. The resultant mortality was in the 20% range,
leading us to abandon this approach in such patients.38
Others, however, have continued to apply the hybrid
approach with acceptable results.39
Although slow to evolve from an engineering and
regulatory perspective, total endovascular repair of exten-
sive TAA is on the horizon. Yet the scant available
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Volume 58, Number 2 Lancaster et al 289information from the true experts advancing this tech-
nology indicates overall outcomes have still not equaled
those of open repair with spinal cord protection strategies.
Greenberg et al reported a series of 633 patients under-
going endovascular repair of TAAs or juxtarenal abdominal
aortic aneurysms.40 In that cohort, 188 patients underwent
repair of extent I-III TAAs, although it seems likely that
many patients were not candidates for open surgery,
making direct comparison between these reports unten-
able. Of that subset of 188 patients, the 30-day mortality
was 5.9%, and the 4-year survival was estimated to be 59%.
A direct comparison by Greenberg et al of open and
endovascular outcomes for TAAs was reported in 2008.41
That series reported a borderline improvement in spinal
cord ischemia rates for those undergoing endovascular
repair. It is noteworthy, however, that there was a signiﬁ-
cant difference in the extent of aneurysms between the
groups, with more extent IV aneurysms found in the endo-
vascular group. Nonetheless, the incidence of spinal cord
ischemia for those with extent I-III TAA in the endovascu-
lar group was 10%.41
A parallel series outlining the experience of Chuter’s
group, reported early and intermediate results of endovas-
cular TAA repair in 81 patients.8 There were zero extent I
aneurysms in this series, and 40 patients with extent II and
III disease. The overall results in that study were notable
for signiﬁcantly worse outcomes in women. In particular,
10.6% of women expired, and another 10.6% of women
were permanently paralyzed. This is in contrast to 1.6%
of men who suffered similar outcomes.
CONCLUSIONS
The present study provides further evidence that distal
aortic perfusion with continuous monitoring of MEVPs in
order to guide selective reimplantation of intercostal arteries
is the preferred method for open repair of extent I-III
TAAs.
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